Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant

Bibliographic Details
Main Authors: Gen Li, Zhongcheng Zhou, Peng Du, Meixiao Zhan, Ning Li, Xinxin Xiong, Shengjun Tang, Miao Man, Daniel T. Baptista-Hon, Ligong Lu
Format: Article
Language:English
Published: Nature Publishing Group 2022-07-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-022-01062-3
_version_ 1811287422044995584
author Gen Li
Zhongcheng Zhou
Peng Du
Meixiao Zhan
Ning Li
Xinxin Xiong
Shengjun Tang
Miao Man
Daniel T. Baptista-Hon
Ligong Lu
author_facet Gen Li
Zhongcheng Zhou
Peng Du
Meixiao Zhan
Ning Li
Xinxin Xiong
Shengjun Tang
Miao Man
Daniel T. Baptista-Hon
Ligong Lu
author_sort Gen Li
collection DOAJ
first_indexed 2024-04-13T03:18:10Z
format Article
id doaj.art-1679f9432d854ad6b0495b3511bf7367
institution Directory Open Access Journal
issn 2059-3635
language English
last_indexed 2024-04-13T03:18:10Z
publishDate 2022-07-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj.art-1679f9432d854ad6b0495b3511bf73672022-12-22T03:04:50ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352022-07-01711310.1038/s41392-022-01062-3Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variantGen Li0Zhongcheng Zhou1Peng Du2Meixiao Zhan3Ning Li4Xinxin Xiong5Shengjun Tang6Miao Man7Daniel T. Baptista-Hon8Ligong Lu9Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityGuangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityGuangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityZhuhai Precision Medicine Center, Zhuhai People’s Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of TechnologyGuangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityGuangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityGuangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityZhuhai Precision Medicine Center, Zhuhai People’s Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of TechnologyZhuhai Precision Medicine Center, Zhuhai People’s Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of TechnologyZhuhai Precision Medicine Center, Zhuhai People’s Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of Technologyhttps://doi.org/10.1038/s41392-022-01062-3
spellingShingle Gen Li
Zhongcheng Zhou
Peng Du
Meixiao Zhan
Ning Li
Xinxin Xiong
Shengjun Tang
Miao Man
Daniel T. Baptista-Hon
Ligong Lu
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Signal Transduction and Targeted Therapy
title Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
title_full Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
title_fullStr Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
title_full_unstemmed Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
title_short Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
title_sort heterologous mrna vaccine booster increases neutralization of sars cov 2 omicron ba 2 variant
url https://doi.org/10.1038/s41392-022-01062-3
work_keys_str_mv AT genli heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT zhongchengzhou heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT pengdu heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT meixiaozhan heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT ningli heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT xinxinxiong heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT shengjuntang heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT miaoman heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT danieltbaptistahon heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant
AT ligonglu heterologousmrnavaccineboosterincreasesneutralizationofsarscov2omicronba2variant